| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.61 | 0.03 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.03 |